IL17A and prostate cancer: These targets were significantly enriched in several critical pathways, including antigen processing and presentation, the IL-17 signaling pathway, prostate cancer, and Th17 cell differentiation, which are implicated in immune regulation, inflammatory responses, and tumorigenesis.